Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Assertio Holdings Return on Tangible Equity 2010-2025 | ASRT

Current and historical return on tangible equity values for Assertio Holdings (ASRT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Assertio Holdings Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.03B $0.04B -83.22%
2024-12-31 $-0.02B $0.04B -62.41%
2024-09-30 $-0.07B $0.04B -217.32%
2024-06-30 $-0.35B $0.03B -1504.35%
2024-03-31 $-0.33B $0.03B -1043.75%
2023-12-31 $-0.33B $0.03B -840.51%
2023-09-30 $-0.19B $0.00B -467.92%
2023-06-30 $0.10B $0.07B 395.96%
2023-03-31 $0.10B $0.06B -956.10%
2022-12-31 $0.11B $0.03B -224.49%
2022-09-30 $0.03B $-0.06B -30.77%
2022-06-30 $0.03B $-0.07B -28.65%
2022-03-31 $0.00B $-0.10B -4.15%
2021-12-31 $0.00B $-0.11B 0.00%
2021-09-30 $-0.03B $-0.08B 28.36%
2021-06-30 $-0.04B $-0.09B 37.69%
2021-03-31 $-0.06B $-0.09B 53.11%
2020-12-31 $-0.03B $-0.15B 33.53%
2020-09-30 $-0.20B $-0.14B 148.12%
2020-06-30 $-0.18B $-0.11B 96.44%
2020-03-31 $-0.16B $0.06B 59.60%
2019-12-31 $-0.22B $-0.34B 54.09%
2019-09-30 $-0.05B $-0.37B 11.26%
2019-06-30 $0.00B $-0.44B 0.87%
2019-03-31 $-0.01B $-0.46B 2.25%
2018-12-31 $0.04B $-0.47B -7.18%
2018-09-30 $0.03B $-0.48B -5.06%
2018-06-30 $-0.04B $-0.55B 6.09%
2018-03-31 $-0.04B $-0.56B 6.85%
2017-12-31 $-0.10B $-0.62B 16.25%
2017-09-30 $-0.11B $-0.63B 17.80%
2017-06-30 $-0.11B $-0.64B 17.26%
2017-03-31 $-0.10B $-0.65B 14.66%
2016-12-31 $-0.09B $-0.65B 13.55%
2016-09-30 $-0.08B $-0.64B 11.38%
2016-06-30 $-0.08B $-0.66B 11.00%
2016-03-31 $-0.09B $-0.68B 12.35%
2015-12-31 $-0.08B $-0.69B 16.98%
2015-09-30 $0.05B $-0.69B -23.67%
2015-06-30 $0.07B $-0.72B 487.27%
2015-03-31 $0.10B $0.29B 46.74%
2014-12-31 $0.13B $0.29B 79.64%
2014-09-30 $0.08B $0.19B 74.18%
2014-06-30 $0.08B $0.10B 107.74%
2014-03-31 $0.07B $0.08B 105.10%
2013-12-31 $0.04B $0.06B 76.19%
2013-09-30 $0.00B $0.06B -3.40%
2013-06-30 $-0.01B $0.06B -17.02%
2013-03-31 $-0.03B $0.06B -44.64%
2012-12-31 $-0.03B $0.06B -43.48%
2012-09-30 $-0.04B $0.06B -49.54%
2012-06-30 $-0.05B $0.06B -50.39%
2012-03-31 $-0.04B $0.10B -33.85%
2011-12-31 $0.07B $0.11B 58.95%
2011-09-30 $0.09B $0.12B 87.76%
2011-06-30 $0.10B $0.13B 131.97%
2011-03-31 $0.11B $0.13B 230.11%
2010-12-31 $0.00B $0.02B 21.62%
2010-09-30 $0.00B $0.02B -11.94%
2010-06-30 $0.00B $0.02B -18.46%
2010-03-31 $-0.02B $0.01B -109.68%
2009-12-31 $-0.02B $0.02B -126.03%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.068B $0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.828B 31.09
Zoetis (ZTS) United States $65.615B 24.48
Daiichi Sankyo, - (DSNKY) Japan $46.658B 23.91
Takeda Pharmaceutical (TAK) Japan $45.056B 9.19
BeOne Medicines - (ONC) Cayman Islands $32.772B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.075B 0.00
Summit Therapeutics (SMMT) United States $20.104B 0.00
Merck (MKKGY) Germany $16.129B 11.82
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $13.274B 11.49
Neurocrine Biosciences (NBIX) United States $12.786B 38.14
Orion OYJ (ORINY) Finland $11.517B 27.76
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.607B 46.52
Grifols, S.A (GRFS) Spain $7.412B 0.00
Corcept Therapeutics (CORT) United States $7.317B 61.06
Ionis Pharmaceuticals (IONS) United States $6.859B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.709B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.334B 0.00
Hypermarcas (HYPMY) Brazil $2.876B 18.92
Crinetics Pharmaceuticals (CRNX) United States $2.607B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.576B 9.03
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.454B 13.27
NewAmsterdam Pharma (NAMS) Netherlands $2.389B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.246B 0.00
Ocular Therapeutix (OCUL) United States $1.899B 0.00
ARS Pharmaceuticals (SPRY) United States $1.687B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.664B 0.00
Dyne Therapeutics (DYN) United States $1.430B 0.00
Evotec AG (EVO) Germany $1.428B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.417B 20.57
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Harrow (HROW) United States $1.146B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.072B 0.00
Ardelyx (ARDX) United States $1.036B 0.00
Akebia Therapeutics (AKBA) United States $0.977B 0.00
Collegium Pharmaceutical (COLL) United States $0.966B 5.21
Enliven Therapeutics (ELVN) United States $0.919B 0.00
Xeris Biopharma Holdings (XERS) United States $0.841B 0.00
ProKidney (PROK) United States $0.825B 0.00
Cronos Group (CRON) Canada $0.752B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.688B 0.00
KalVista Pharmaceuticals (KALV) United States $0.660B 0.00
Zevra Therapeutics (ZVRA) United States $0.607B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Organogenesis (ORGO) United States $0.572B 0.00
Xencor (XNCR) United States $0.568B 0.00
Tourmaline Bio (TRML) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.545B 0.00
USANA Health Sciences (USNA) United States $0.537B 10.81
Elite Pharmaceuticals (ELTP) United States $0.520B 0.00
Oruka Therapeutics (ORKA) United States $0.509B 0.00
Bioventus (BVS) United States $0.508B 12.88
Siga Technologies (SIGA) United States $0.462B 9.64
Savara (SVRA) United States $0.448B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 10.58
Aquestive Therapeutics (AQST) United States $0.379B 0.00
AleAnna (ANNA) United States $0.354B 0.00
Nanobiotix S.A (NBTX) France $0.321B 0.00
4D Molecular Therapeutics (FDMT) United States $0.297B 0.00
Altimmune (ALT) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.16
Aldeyra Therapeutics (ALDX) United States $0.288B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.287B 0.00
Nektar Therapeutics (NKTR) United States $0.285B 0.00
Esperion Therapeutics (ESPR) United States $0.277B 0.00
Heron Therapeutics (HRTX) United States $0.258B 0.00
OmniAb (OABI) United States $0.233B 0.00
Galectin Therapeutics (GALT) United States $0.231B 0.00
Larimar Therapeutics (LRMR) United States $0.220B 0.00
MediWound (MDWD) Israel $0.200B 0.00
China SXT Pharmaceuticals (SXTC) China $0.197B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Lyell Immunopharma (LYEL) United States $0.163B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Liminatus Pharma (LIMN) United States $0.154B 0.00
Lexeo Therapeutics (LXEO) United States $0.153B 0.00
Avita Medical (RCEL) United States $0.136B 0.00
Korro Bio (KRRO) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.125B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.114B 0.00
Inhibikase Therapeutics (IKT) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
Surrozen (SRZN) United States $0.094B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Achieve Life Sciences (ACHV) Canada $0.088B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Champions Oncology (CSBR) United States $0.085B 19.25
Metagenomi (MGX) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Nutriband (NTRB) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
VAXART, INC (VXRT) United States $0.081B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.064B 0.00
Wellgistics Health (WGRX) United States $0.064B 0.00
Rafael Holdings (RFL) United States $0.061B 0.00
DURECT (DRRX) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 39.11
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
Jupiter Neurosciences (JUNS) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Gain Therapeutics (GANX) United States $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Plus Therapeutics (PSTV) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.031B 0.00
FibroGen (FGEN) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Lipocine (LPCN) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 11.83
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.33
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00